Sponsored Articles

Lengthy early-development timelines are common across new and emerging biotech companies for a multitude of reasons. Striking the right balance of speed, quality, risk, and investment allows you to shorten…

ICROM and PolyCrystalLine SpA have announced their strategic and exclusive partnership to provide integrated solutions for chemical development and custom manufacturing of APIs. The two Italian companies will offer their…

The approvals of Roche’s Luxturna® (2017) for inherited retinal disease and Novartis’ Zolgensma® (2019) for spinal muscular atrophy are indicative of a resurgence in the gene therapy field after a…

With the industry moving to more personalized medicine and delivering genetic material to patients to treat conditions resulting from genetic mutations, we speak to Sean Canavan, Operations Manager at Almac’s…

Virtual pharmaceutical companies often have strong regulatory and clinical teams, but lack the resources needed to address the complexities of the complete product development and commercialization cycle. Partnering with a…

Growing demand for patient-centered healthcare presents fresh challenges for pharmaceutical product development and manufacturing. As precision medicine gains traction in research and development pipelines and the pharmaceutical marketplace, specialist providers…

With much of the world now reliant on China and India for pharmaceuticals and the raw materials needed to make them, the risks of this reliance are now coming into…

Since its introduction in the 1980s, the market for orally disintegrating tablets (ODTs) has grown annually, and ODTs are now available in a variety of therapeutic areas, both over-the-counter and…

Pharmaceutical and biopharmaceutical companies have been extensively using contract research organizations (CROs) to meet their challenging needs in R&D and standard work for several decades. A noticeable shift occurred in…